{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:16:19Z","timestamp":1778400979354,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/18013-8"],"award-info":[{"award-number":["2019\/18013-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/19714-7"],"award-info":[{"award-number":["2018\/19714-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.369858\/2019-00"],"award-info":[{"award-number":["88887.369858\/2019-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Terapia Celular","award":["2013\/08135-2"],"award-info":[{"award-number":["2013\/08135-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-022-01825-6","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:02:42Z","timestamp":1664485362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-6369","authenticated-orcid":false,"given":"Vitor Leonardo","family":"Bassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Dessotti","family":"Barretto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Campos","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Vianna Bonini","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Sarri","family":"Binelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo Lettieri","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Fontanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Cardoso","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena L\u00f4bo","family":"de Figueiredo Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiani Gai","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fab\u00edola Atti\u00e9","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"6","key":"1825_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","volume":"129","author":"W Vainchenker","year":"2017","unstructured":"Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood. 2017;129(6):667\u201379. https:\/\/doi.org\/10.1182\/blood-2016-10-695940.","journal-title":"Blood"},{"issue":"1","key":"1825_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","volume":"14","author":"G Greenfield","year":"2021","unstructured":"Greenfield G, McMullin MF, Mills K. Molecular pathogenesis of the myeloproliferative neoplasms. J Hematol Oncol. 2021;14(1):103. https:\/\/doi.org\/10.1186\/s13045-021-01116-z.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"1825_CR3","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"key":"1825_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376:2168\u201381. https:\/\/doi.org\/10.1056\/NEJMra1406186.","journal-title":"N Engl J Med"},{"key":"1825_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3978\/j.issn.2306-9759.2016.02.03","volume":"3","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Morrone K, Bartenstein M, et al. Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-\u03b2. Stem Cell Investig. 2016;3:5. https:\/\/doi.org\/10.3978\/j.issn.2306-9759.2016.02.03.","journal-title":"Stem Cell Investig."},{"issue":"14","key":"1825_CR6","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood. 2012;119(14):3219\u201325. https:\/\/doi.org\/10.1182\/blood-2011-11-394775.","journal-title":"Blood"},{"issue":"5","key":"1825_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MOH.0000000000000669","volume":"28","author":"HFE Gleitz","year":"2021","unstructured":"Gleitz HFE, Benabid A, Schneider RK. Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms. Curr Opin Hematol. 2021;28(5):364\u201371. https:\/\/doi.org\/10.1097\/MOH.0000000000000669.","journal-title":"Curr Opin Hematol"},{"key":"1825_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/606819","author":"AG Fleischman","year":"2015","unstructured":"Fleischman AG. Inflammation as a driver of clonal evolution in myeloproliferative neoplasm. Mediators Inflamm. 2015. https:\/\/doi.org\/10.1155\/2015\/606819.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"1825_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.htct.2017.12.003","volume":"40","author":"MC Cacemiro","year":"2018","unstructured":"Cacemiro MC, Cominal JG, Tognon R, et al. Philadelfia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematol Transfus Cell Ther. 2018;40(2):120\u201331. https:\/\/doi.org\/10.1016\/j.htct.2017.12.003.","journal-title":"Hematol Transfus Cell Ther."},{"key":"1825_CR10","doi-asserted-by":"publisher","first-page":"665037","DOI":"10.3389\/fonc.2021.665037","volume":"11","author":"JG Cominal","year":"2021","unstructured":"Cominal JG, Cacemiro MDC, Berzoti-Coelho MG, et al. Bone marrow soluble mediator signatures of patients with philadelphia chromosome-negative myeloproliferative neoplasms. Front Oncol. 2021;11:665037. https:\/\/doi.org\/10.3389\/fonc.2021.665037.","journal-title":"Front Oncol"},{"key":"1825_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/149185","author":"G Landskron","year":"2014","unstructured":"Landskron G, De Le FM, Thuwajit P, et al. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014. https:\/\/doi.org\/10.1155\/2014\/149185.","journal-title":"J Immunol Res"},{"key":"1825_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/415024","author":"C Desterke","year":"2015","unstructured":"Desterke C, Christophe Martinaud C, Ruzehaji N, et al. Inflammation as a keystone of bone marrow stroma alterations in primary myelofibrosis. Mediators Inflamm. 2015. https:\/\/doi.org\/10.1155\/2015\/415024.","journal-title":"Mediators Inflamm"},{"issue":"23","key":"1825_CR13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood.V126.23.1637.1637","volume":"126","author":"AQ Arantes","year":"2015","unstructured":"Arantes AQ, Leal CT, Silva CA, et al. Decreased activity of NK cells in myeloproliferative neoplasms. Blood. 2015;126(23):1637. https:\/\/doi.org\/10.1182\/blood.V126.23.1637.1637.","journal-title":"Blood"},{"issue":"7","key":"1825_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3390\/cancers12071763","volume":"12","author":"MO Holmstr\u00f6m","year":"2020","unstructured":"Holmstr\u00f6m MO, Hasselbalch HC, Andersen MH. Cancer immune therapy for philadelphia chromosome-negative chronic myeloproliferative neoplasms. Cancers. 2020;12(7):1763. https:\/\/doi.org\/10.3390\/cancers12071763.","journal-title":"Cancers"},{"issue":"2","key":"1825_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1034\/j.1600-0609.2000.90262.x","volume":"65","author":"F Cervantes","year":"2000","unstructured":"Cervantes F, Hern\u00e1ndez-Boluda JC, Villamor N, et al. Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis. Eur J Haematol. 2000;65(2):104\u20138. https:\/\/doi.org\/10.1034\/j.1600-0609.2000.90262.x.","journal-title":"Eur J Haematol"},{"issue":"9","key":"1825_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","volume":"40","author":"V Skov","year":"2012","unstructured":"Skov V, Thomassen M, Riley CH, et al. Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis. Exp Hematol. 2012;40(9):771-780.e19. https:\/\/doi.org\/10.1016\/j.exphem.2012.05.011.","journal-title":"Exp Hematol"},{"issue":"1","key":"1825_CR17","doi-asserted-by":"publisher","first-page":"1782575","DOI":"10.1080\/2162402X.2020.1782575","volume":"9","author":"M Barone","year":"2020","unstructured":"Barone M, Catani L, Ricci F, et al. The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis. Oncoimmunology. 2020;9(1):1782575. https:\/\/doi.org\/10.1080\/2162402X.2020.1782575.","journal-title":"Oncoimmunology"},{"issue":"5","key":"1825_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/bjh.17850","volume":"196","author":"M Strickland","year":"2022","unstructured":"Strickland M, Quek L, Psaila B. The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy. Br J Haematol. 2022;196(5):1149\u201358. https:\/\/doi.org\/10.1111\/bjh.17850.","journal-title":"Br J Haematol"},{"issue":"3","key":"1825_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/ijms22031143","volume":"22","author":"F Ferrer-Mar\u00edn","year":"2021","unstructured":"Ferrer-Mar\u00edn F, Cuenca-Zamora E, Guijarro-Carrillo PJ, et al. Emerging role of neutrophils in the thrombosis of chronic myeloproliferative neoplasms. Int J Mol Sci. 2021;22(3):1143. https:\/\/doi.org\/10.3390\/ijms22031143.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1825_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3324\/haematol.2018.205989","volume":"104","author":"M Bar-Natan","year":"2019","unstructured":"Bar-Natan M, Hoffman R. New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches. Haematologica. 2019;104(1):3\u20136. https:\/\/doi.org\/10.3324\/haematol.2018.205989.","journal-title":"Haematologica"},{"key":"1825_CR21","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fimmu.2018.01726","volume":"9","author":"P Sampath","year":"2018","unstructured":"Sampath P, Moideen K, Ranganathan UD, et al. Monocyte subsets: phenotypes and function in tuberculosis infection. Front Immunol. 2018;9:1726. https:\/\/doi.org\/10.3389\/fimmu.2018.01726.","journal-title":"Front Immunol"},{"key":"1825_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: phenotypical vs functional differentiation. Front Immunol. 2014;5:514. https:\/\/doi.org\/10.3389\/fimmu.2014.00514.","journal-title":"Front Immunol"},{"issue":"2","key":"1825_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12307-012-0123-x","volume":"6","author":"DM Richards","year":"2013","unstructured":"Richards DM, Hettinger J, Feuerer M. Monocytes and macrophages in cancer: development and functions. Cancer Microenviron. 2013;6(2):179\u201391. https:\/\/doi.org\/10.1007\/s12307-012-0123-x.","journal-title":"Cancer Microenviron."},{"issue":"1","key":"1825_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4049\/jimmunol.1900998","volume":"204","author":"PB Narasimhan","year":"2020","unstructured":"Narasimhan PB, Eggert T, Zhu YP, et al. Patrolling monocytes control NK cell expression of activating and stimulatory receptors to curtail lung metastases. J Immunol. 2020;204(1):192\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1900998.","journal-title":"J Immunol"},{"issue":"2","key":"1825_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/modpathol.2012.165","volume":"26","author":"L Boiocchi","year":"2013","unstructured":"Boiocchi L, Espinal-Witter R, Geyer JT, et al. Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol. 2013;26(2):204\u201312. https:\/\/doi.org\/10.1038\/modpathol.2012.165.","journal-title":"Mod Pathol"},{"issue":"1","key":"1825_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11899-021-00660-2","volume":"17","author":"E Morsia","year":"2022","unstructured":"Morsia E, Gangat N. Myeloproliferative neoplasms with monocytosis. Curr Hematol Malig Rep. 2022;17(1):46\u201351. https:\/\/doi.org\/10.1007\/s11899-021-00660-2.","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"1825_CR27","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/cells9092136","volume":"9","author":"E Masselli","year":"2020","unstructured":"Masselli E, Pozzi G, Gobbi G, et al. Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants. Cells. 2020;9(9):2136. https:\/\/doi.org\/10.3390\/cells9092136.","journal-title":"Cells"},{"issue":"1","key":"1825_CR28","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1038\/s41467-018-05315-0","volume":"9","author":"G Escobar","year":"2018","unstructured":"Escobar G, Barbarossa L, Barbiera G, et al. Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens. Nat Commun. 2018;9(1):2896. https:\/\/doi.org\/10.1038\/s41467-018-05315-0.","journal-title":"Nat Commun"},{"issue":"8","key":"1825_CR29","first-page":"12297","volume":"8","author":"XQ Jiang","year":"2015","unstructured":"Jiang XQ, Zhang L, Liu H, et al. Expansion of CD14(+)CD16(+) monocytes is related to acute leukemia. Int J Clin Exp Med. 2015;8(8):12297\u2013306.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"1825_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3324\/haematol.2012.073080","volume":"98","author":"R Maffei","year":"2013","unstructured":"Maffei R, Bulgarelli J, Fiorcari S, et al. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation. Haematologica. 2013;98(7):1115\u201323. https:\/\/doi.org\/10.3324\/haematol.2012.073080.","journal-title":"Haematologica"},{"issue":"1","key":"1825_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.17219\/acem\/76262","volume":"28","author":"E Wypasek","year":"2019","unstructured":"Wypasek E, Padjas A, Szyma\u0144ska M, et al. Non-classical and intermediate monocytes in patients following venous thromboembolism: Links with inflammation. Adv Clin Exp Med. 2019;28(1):51\u20138. https:\/\/doi.org\/10.17219\/acem\/76262.","journal-title":"Adv Clin Exp Med."},{"issue":"5","key":"1825_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1160\/TH16-08-0614","volume":"117","author":"K Urbanski","year":"2017","unstructured":"Urbanski K, Ludew D, Filip G, et al. CD14+CD16++ \u201cnonclassical\u201d monocytes are associated with endothelial dysfunction in patients with coronary artery disease. Thromb Haemost. 2017;117(5):971\u201380. https:\/\/doi.org\/10.1160\/TH16-08-0614.","journal-title":"Thromb Haemost"},{"key":"1825_CR33","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1182\/blood-2019-131128","volume":"134","author":"JS Fowles","year":"2019","unstructured":"Fowles JS, Fisher DAC, Zhou A, et al. Altered dynamics of Monocyte subpopulations and pro-inflammatory signaling pathways in polycythemia vera revealed by mass cytometry. Blood. 2019;134:4210.","journal-title":"Blood"},{"issue":"5","key":"1825_CR34","doi-asserted-by":"publisher","first-page":"C761","DOI":"10.1152\/ajpcell.00326.2020","volume":"320","author":"S Tahir","year":"2021","unstructured":"Tahir S, Steffens S. Nonclassical monocytes in cardiovascular physiology and disease. Am J Physiol Cell Physiol. 2021;320(5):C761\u201370. https:\/\/doi.org\/10.1152\/ajpcell.00326.2020.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1825_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12885-016-2405-z","volume":"4","author":"M Scarpa","year":"2016","unstructured":"Scarpa M, Scarpa M, Castagliuolo I, et al. CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis. BMC Cancer. 2016;4:388. https:\/\/doi.org\/10.1186\/s12885-016-2405-z.","journal-title":"BMC Cancer"},{"key":"1825_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-802585-7.00002-9","volume-title":"Developing costimulatory molecules for immunotherapy of diseases","author":"MA Mir","year":"2015","unstructured":"Mir MA. Concept of reverse costimulation and its role in diseases. In: Mir MA, editor. Developing costimulatory molecules for immunotherapy of diseases. New York: Elsevier; 2015. p. 45\u201381. https:\/\/doi.org\/10.1016\/B978-0-12-802585-7.00002-9."},{"key":"1825_CR37","first-page":"3074902","volume":"2016","author":"T Skirecki","year":"2016","unstructured":"Skirecki T, Mikaszewska-Sokolewicz M, Hoser G, et al. The early expression of HLA-DR and CD64 myeloid markers is specifically compartmentalized in the blood and lungs of patients with septic shock. Hind Mediat Inflamm. 2016;2016:3074902.","journal-title":"Hind Mediat Inflamm."},{"issue":"5","key":"1825_CR38","first-page":"975","volume":"74","author":"P Chaux","year":"1996","unstructured":"Chaux P, Moutet M, Faivre J, et al. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7\u20131 and B7\u20132 costimulatory molecules of the T-cell activation. Lab Invest. 1996;74(5):975\u201383.","journal-title":"Lab Invest"},{"key":"1825_CR39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00262-004-0565-1","volume":"53","author":"S Ugurel","year":"2004","unstructured":"Ugurel S, Lindemann M, Schadendorf D, et al. Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation? Cancer Immunol Immunother. 2004;53:1051. https:\/\/doi.org\/10.1007\/s00262-004-0565-1.","journal-title":"Cancer Immunol Immunother"},{"issue":"17","key":"1825_CR40","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1089\/ars.2012.4834","volume":"18","author":"A Etzerodt","year":"2013","unstructured":"Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18(17):2352\u201363. https:\/\/doi.org\/10.1089\/ars.2012.4834.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"1825_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/ejh.13371","volume":"104","author":"SL Kvorning","year":"2020","unstructured":"Kvorning SL, Nielsen MC, Andersen NF, et al. Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma. Eur J Haematol. 2020;104(5):409\u201319. https:\/\/doi.org\/10.1111\/ejh.13371.","journal-title":"Eur J Haematol"},{"key":"1825_CR42","doi-asserted-by":"publisher","first-page":"585297","DOI":"10.3389\/fonc.2020.585297","volume":"10","author":"S Qian","year":"2020","unstructured":"Qian S, Zhang H, Dai H, et al. Is sCD163 a clinical significant prognostic value in cancers? a systematic review and meta-analysis. Front Oncol. 2020;10:585297. https:\/\/doi.org\/10.3389\/fonc.2020.585297.","journal-title":"Front Oncol"},{"key":"1825_CR43","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fimmu.2017.00892","volume":"8","author":"HH Van Acker","year":"2017","unstructured":"Van Acker HH, Capsomidis A, Smits EL, et al. CD56 in the immune system: more than a marker for cytotoxicity? Front Immunol. 2017;8:892. https:\/\/doi.org\/10.3389\/fimmu.2017.00892.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"1825_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2011.01.020","volume":"337","author":"C Papewalis","year":"2011","unstructured":"Papewalis C, Jacobs B, Baran AM, et al. Increased numbers of tumor-lysing monocytes in cancer patients. Mol Cell Endocrinol. 2011;337(1\u20132):52\u201361. https:\/\/doi.org\/10.1016\/j.mce.2011.01.020.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1825_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4049\/jimmunol.2100830","volume":"208","author":"TS Dutt","year":"2022","unstructured":"Dutt TS, LaVergne SM, Webb TL, et al. Comprehensive immune profiling reveals CD56+ monocytes and CD31+ endothelial cells are increased in severe COVID-19 disease. J Immunol. 2022;208(3):685\u201396. https:\/\/doi.org\/10.4049\/jimmunol.2100830.","journal-title":"J Immunol"},{"issue":"3","key":"1825_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5581\/1516-8484.20110054","volume":"33","author":"AP Alegretti","year":"2011","unstructured":"Alegretti AP, Bittar CM, Bittencourt R, et al. The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia. Rev Bras Hematol Hemoter. 2011;33(3):202\u20136. https:\/\/doi.org\/10.5581\/1516-8484.20110054.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"3","key":"1825_CR47","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1097\/HS9.0000000000000371","volume":"4","author":"NF \u00d8bro","year":"2020","unstructured":"\u00d8bro NF, Grinfeld J, Belmonte M, et al. Longitudinal cytokine profiling identifies GRO-\u03b1 and EGF as potential biomarkers of disease progression in essential thrombocythemia. Hemasphere. 2020;4(3):e371. https:\/\/doi.org\/10.1097\/HS9.0000000000000371.","journal-title":"Hemasphere"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01825-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01825-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01825-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:47:57Z","timestamp":1744206477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01825-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01825-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"223"}}